Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Fabrice Viviani
CEO | Chief Executive Officer | - | 04/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 23/04/2018 |
Stéphane Gerart
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 13/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 02/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 23/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 23/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% | ||
| 23/10/22 | Sell | Head of Human Resources | 18,140 | 0.2649% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.14% | - | - | 105M | |
| +0.87% | +6.29% | +2.05% | +7.33% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +5.46% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.55% | +0.81% | +13.93% | +19.37% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | +1.18% | +6.43% | +70.99% | +103.37% | 26.92B | |
| Weighted average by Cap. | +1.36% | +6.73% | +88.48% | +131.08% |
Employees
236
